Novartis Investigative Site

Shimotsuga Gun, Tochigi 321-0293

0 studies enrolling now · 1 studies all time

What they study most

Chronic Myelogenous Leukemia

Studies at this site

• Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients — Completed